M. Armeno, R. Caraballo, M. Vaccarezza, MJ. Alberti, V. Ríos, S. Galicchio, ES. de Grandis, G. Mestre, N. Escobal, P. Matarrese, R. Viollaz, A. Agostinho, C. Díez, A. Cresta, A. Cabrera, V. Blanco, H. Ferrero, V. Gambarini, P. Sosa, C. Bouquet, L. Caramuta, S. Guisande, B. Gamboni, A. Hassan, L. Pesce, L. Argumedo, C. Dlugoszewski, MG. DeMartini, et al. (2014). [National consensus on the ketogenic diet]. Revista de neurologia, 59(5), 213-23.

PubMed 25156026

[Abstract]
INTRODUCTION: Epilepsy is a chronic disease with onset in infancy affecting 0.5-1% of the population. One third of the patients is refractory to antiepileptic drugs and they pose a challenge for the health care team. The ketogenic diet is an effective, non-pharmacological, alternative treatment for the management of refractory epilepsy.

AIMS: There is a need to establish guidelines for the adequate and increased use of the ketogenic diet in Spanish-speaking countries. The National Committee on the Ketogenic Diet, consisting of paediatric neurologists, clinical nutritionists, and dietitians, of the Argentine Society of Child Neurology has developed this consensus statement to standardize the use of the ketogenic diet based on the literature and clinical experience.

DEVELOPMENT: Patient selection, pre-treatment family counseling, drug interactions, micronutrient supplementation, adverse effects, and discontinuation of the diet are discussed.

CONCLUSIONS: The ketogenic diet is an effective treatment for children with refractory epilepsy. Education and collaboration of the patient and their family is essential. The patient should be managed by an experienced multidisciplinary team using a protocol. The formation of a national multidisciplinary team and the publication of this document provide possibilities for new centers to integrate the ketogenic diet into their treatment options.